These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37823255)

  • 41. Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy.
    Higgins AY; Annapureddy AR; Wang Y; Minges KE; Bellumkonda L; Lampert R; Rosenfeld LE; Jacoby DL; Curtis JP; Miller EJ; Freeman JV
    Am Heart J; 2022 Apr; 246():21-31. PubMed ID: 34968442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of prognosis in isolated versus systemic manifestations of cardiac sarcoidosis.
    Mactaggart S; Ahmed R
    Curr Probl Cardiol; 2024 Aug; 49(8):102671. PubMed ID: 38782195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.
    Nordenswan HK; Lehtonen J; Ekström K; Kandolin R; Simonen P; Mäyränpää M; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006145. PubMed ID: 30354309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
    Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
    Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction.
    Chiba T; Nakano M; Hasebe Y; Kimura Y; Fukasawa K; Miki K; Morosawa S; Takanami K; Ota H; Fukuda K; Shimokawa H
    J Cardiol; 2020 Jan; 75(1):34-41. PubMed ID: 31277963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The long-term prognostic significance of heart failure in sarcoidosis patients ─ a cohort study.
    Etinger R; Comaneshter D; Amital H; Cohen AD; Tiosano S
    Postgrad Med; 2021 Mar; 133(2):202-208. PubMed ID: 33019840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics associated with pacing-induced cardiac dysfunction: a high incidence of undiagnosed cardiac sarcoidosis before permanent pacemaker implantation.
    Wakabayashi Y; Mitsuhashi T; Akashi N; Hayashi T; Umemoto T; Sugawara Y; Fujita H; Momomura SI
    Heart Vessels; 2018 Dec; 33(12):1505-1514. PubMed ID: 29931541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Outcomes and Predictors of Long-Term Survival in Patients With and Without Previously Known Extracardiac Sarcoidosis Using Machine Learning: A Swedish Multicenter Study.
    Bobbio E; Eldhagen P; Polte CL; Hjalmarsson C; Karason K; Rawshani A; Darlington P; Kullberg S; Sörensson P; Bergh N; Bollano E
    J Am Heart Assoc; 2023 Aug; 12(15):e029481. PubMed ID: 37489729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New Zealand.
    Chow KL; O'Donnell JL; Crozier I
    Int J Cardiol; 2022 Jun; 357():128-133. PubMed ID: 35395288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience.
    Bobbio E; Hjalmarsson C; Björkenstam M; Polte CL; Oldfors A; Lindström U; Dahlberg P; Bartfay SE; Szamlewski P; Taha A; Sakiniene E; Karason K; Bergh N; Bollano E
    BMC Cardiovasc Disord; 2022 Apr; 22(1):192. PubMed ID: 35473644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of late gadolinium enhancement in predicting arrhythmic events in cardiac sarcoidosis patients - a mini-review.
    Bazoukis G; Liatakis I; Vassiliou VS; Tse G; Gounopoulos P; Saplaouras A; Letsas KP; Vlachos K; Papadatos SS; Konstantinidou E; Lakoumentas I; Sideris A; Efremidis M
    Acta Cardiol; 2022 Nov; 77(9):768-773. PubMed ID: 35086421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional Myocardial Remodeling Characteristics Correlates With Cardiac Events in Sarcoidosis.
    Lu C; Chen J; Suksaranjit P; Menda Y; Adhaduk M; Jayanna MB; Scalzetti E; Ji J; Wei T; Feiglin D; Liu K
    J Magn Reson Imaging; 2020 Aug; 52(2):499-509. PubMed ID: 31950573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    Yafasova A; Fosbøl EL; Schou M; Gustafsson F; Rossing K; Bundgaard H; Lauridsen MD; Kristensen SL; Torp-Pedersen C; Gislason GH; Køber L; Butt JH
    J Am Coll Cardiol; 2020 Aug; 76(7):767-777. PubMed ID: 32792073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
    Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
    Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
    Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications.
    Viles-Gonzalez JF; Pastori L; Fischer A; Wisnivesky JP; Goldman MG; Mehta D
    Chest; 2013 Apr; 143(4):1085-1090. PubMed ID: 23667912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.
    Cain MA; Metzl MD; Patel AR; Addetia K; Spencer KT; Sweiss NJ; Beshai JF
    Am J Cardiol; 2014 May; 113(9):1556-60. PubMed ID: 24731652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy.
    Steckman DA; Schneider PM; Schuller JL; Aleong RG; Nguyen DT; Sinagra G; Vitrella G; Brun F; Cova MA; Pagnan L; Mestroni L; Varosy PD; Sauer WH
    Am J Cardiol; 2012 Aug; 110(4):575-9. PubMed ID: 22595349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis.
    Fujimoto Y; Matsue Y; Maeda D; Dotare T; Sunayama T; Iso T; Nakamura Y; Singh YS; Akama Y; Yoshioka K; Kitai T; Naruse Y; Taniguchi T; Tanaka H; Okumura T; Baba Y; Nabeta T; Minamino T
    Eur Heart J Open; 2023 Sep; 3(5):oead100. PubMed ID: 37849788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac sarcoidosis and ventricular arrhythmias. A rare association of a rare disease. A retrospective cohort study from the National Inpatient Sample and current evidence for management.
    Salama A; Abdullah A; Wahab A; Eigbire G; Hoefen R; Alweis R
    Cardiol J; 2020; 27(3):272-277. PubMed ID: 30234899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.